OMESIZ 40MG / 10ML
OMESIZ 40 MG/10ML POWDER AND SOLVENT FOR INJECTABLE SOLUTION OMEPRAZOLE
Read all of this leaflet carefully before you start taking this medicine as it contains important information for you.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you. You must not give it to others. The medicine can harm them even if they have the same signs of illness.
- If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
WHAT THIS LEAFLET CONTAINS
- What is OMESIZ and what is it used for
- What you need to know before you are given OMESIZ
- How OMESIZ is administered
- Possible undesirable effects
- How to store OMESIZ
- Package contents and other information
WHAT IS OMESIZ AND WHAT IS IT USED FOR
- OMESIZ contains the active substance omeprazole. It belongs to a group of medicines called ‘proton pump inhibitors’. They work by reducing the amount of acid that is produced by the stomach.
- OMESIZ powder and solvent for solution for injection can be used as an alternative to oral therapy.
WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN OMESIZ
- You should not be given OMESIZ
- if you are allergic (hypersensitive) to omeprazole or any of the other ingredients of this medicine (listed in section 6). if you are allergic to other proton pump inhibitor medicines (eg pantoprazole, lansoprazole, rabeprazole, esomeprazole).
- If you are taking a medicine containing nelfinavir (used for HIV infection).
- If you are not sure, talk to your doctor, nurse or pharmacist before you are given OMESIZ.
WARNINGS AND PRECAUTIONS
- Talk to your doctor or pharmacist before taking OMESIZ.
- OMESIZ can mask the symptoms of other diseases. Therefore, if any of the following events happen to you before or after you are given OMESIZ, tell your doctor immediately:
- She loses a lot of weight for no apparent reason and has difficulty swallowing. Have stomach pains or indigestion.
- Begins vomiting food or blood.
- You have black stools (stools stained with blood).
- You have severe or persistent diarrhea, as omeprazole has been associated with a small increase in infectious diarrhea.
- You have serious liver problems.
TALK TO YOUR DOCTOR BEFORE TAKING OMESIZ
- if you have ever had skin reactions after treatment with a medicine similar to OMESIZ that reduces stomach acid.
- whether a specific blood test is planned (Chromogranin A)
- If you experience a rash, especially on sun-exposed skin areas, talk to your doctor as soon as possible, as you may need to stop your treatment with OMESIZ. Remember to also mention any other adverse effects, such as joint pain.
TELL YOUR DOCTOR OR PHARMACIST IF YOU ARE TAKING ANY OF THE FOLLOWING MEDICINES
- Ketoconazole, itraconazole or voriconazole (used to treat infections caused by fungi)
- Digoxin (used to treat heart problems)
- Diazepam (used to treat anxiety, relax muscles or in epilepsy) Phenytoin (used in epilepsy). If you are taking phenytoin, your doctor needs to monitor you when you start and stop taking OMESIZ
- Medicines used to keep the blood flowing, such as warfarin or other vitamin K blockers. Your doctor may need to monitor when you start and stop taking OMESIZ
- Rifampicin (used to treat tuberculosis) Atazanavir (used to treat HIV infections) Tacrolimus (in organ transplant cases)
- St John’s wort (Hypericum perforatum) (used to treat mild depression) Cilostazol (used to treat intermittent claudication)
- Saquinavir (used to treat HIV infections)
- Clopidogrel (used to prevent blood clots (thrombi).
- If your doctor has prescribed the antibiotics amoxicillin and clarithromycin along with OMESIZ to treat ulcers caused by Helicobacter pylori infection, it is very important that you tell your doctor about any other medicines you are taking.
- pregnancy and breastfeeding
- Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
- Omeprazole is excreted in breast milk but is not likely to influence the infant when therapeutic doses are used.
